Global Bio-absorbable Stents Market Professional Survey Report 2019
A stent is a metallic or a polymer tube implanted into the lumen of any blood vessel or a duct in order to keep the passage open. A variety of stents for different clinical conditions are available in the market. A stent implant is most commonly used for the treatment of cardiac abnormalities such as blocked blood vessels. In addition, stents are implanted in the esophagus to allow the passage of food and beverages in patients suffering from esophageal cancer. They are also inserted in the ureter to prevent obstruction of urine flow from kidney, in the gall bladder to allow passage of bile in patients suffering from gall bladder cancer, and in the abdomen & gastrointestinal tract. A bio-absorbable stent is a special type of stent which can be dissolved or reabsorbed within the patients body.
According to World Health Organization (WHO), cardiovascular diseases are the number one cause of death globally. In 2015, it is estimated that about 17.7 million people died because of cardiovascular diseases and in these deaths, it was estimated that 7.4 million people died because of coronary heart disease and 6.7 million people died of a stroke. Thus, a large number of people are already suffering from these cardiovascular diseases, and with the increase in population the number of people with cardiovascular diseases is expected to rise. This rise in the disease rate is also expected to increase the usage of stents, in turn, it is expected to drive the market during the forecast years. The changing lifestyles, rising obese population, and steep growth in the geriatric population are the major driving factors for the market growth.
The high cost of the device is a major restraint for the bioabsorbable stents market. The cost of the stent depends on the type, which may cost USD 1800. In addition to the cost of the bioabsorbable stent, other aspects such as the cost of the procedure that can add to the cost of bioabsorbable stent’s usage. The high cost of the device hinders the growth of the market, as surgeons prefer the conventional stents over the bioabsorbable stents due to their difference in cost. Along with the high cost, other factors, such as stringent regulatory policies and safety issues related to bioabsorbable stents are also hindering the growth of the market.
Europe has the largest market share in the bioabsorbable stents market, followed by North America. Asia-Pacific is expected to have the highest growth rate in the forecast period, due to the increasing awareness among people about the procedure and the products. The US FDA has approved only one product, namely Abbott Absorb, and it is now commercially available in the US. However, several products are being developed, some are in clinical trials and others in various stages of development, which is an indication of a bright future for this market.
The global Bio-absorbable Stents market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Bio-absorbable Stents volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bio-absorbable Stents market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Bio-absorbable Stents in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Bio-absorbable Stents manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Boston Scientific
Abbott Laboratories
Elixir Medical
Kyoto Medical Planning
F. Hoffmann-La Roche
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Metallic Stents
Polymeric Stents
Segment by Application
PAD
CAD
According to World Health Organization (WHO), cardiovascular diseases are the number one cause of death globally. In 2015, it is estimated that about 17.7 million people died because of cardiovascular diseases and in these deaths, it was estimated that 7.4 million people died because of coronary heart disease and 6.7 million people died of a stroke. Thus, a large number of people are already suffering from these cardiovascular diseases, and with the increase in population the number of people with cardiovascular diseases is expected to rise. This rise in the disease rate is also expected to increase the usage of stents, in turn, it is expected to drive the market during the forecast years. The changing lifestyles, rising obese population, and steep growth in the geriatric population are the major driving factors for the market growth.
The high cost of the device is a major restraint for the bioabsorbable stents market. The cost of the stent depends on the type, which may cost USD 1800. In addition to the cost of the bioabsorbable stent, other aspects such as the cost of the procedure that can add to the cost of bioabsorbable stent’s usage. The high cost of the device hinders the growth of the market, as surgeons prefer the conventional stents over the bioabsorbable stents due to their difference in cost. Along with the high cost, other factors, such as stringent regulatory policies and safety issues related to bioabsorbable stents are also hindering the growth of the market.
Europe has the largest market share in the bioabsorbable stents market, followed by North America. Asia-Pacific is expected to have the highest growth rate in the forecast period, due to the increasing awareness among people about the procedure and the products. The US FDA has approved only one product, namely Abbott Absorb, and it is now commercially available in the US. However, several products are being developed, some are in clinical trials and others in various stages of development, which is an indication of a bright future for this market.
The global Bio-absorbable Stents market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Bio-absorbable Stents volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bio-absorbable Stents market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Bio-absorbable Stents in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Bio-absorbable Stents manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Boston Scientific
Abbott Laboratories
Elixir Medical
Kyoto Medical Planning
F. Hoffmann-La Roche
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Metallic Stents
Polymeric Stents
Segment by Application
PAD
CAD
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
